NCT04364555View on ClinicalTrials.gov

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

July 3, 2024

Study Completion Date

December 31, 2025

Conditions
Oral Lichen Planus
Interventions
DRUG

Clobetasol Propionate

Klobetasol APL oral gel 0.025% is a topical steroid for rinsing the oral cavity. Manufactured by APL, Sweden.

DRUG

Placebo/Klobetasol APL oral gel 0.025%

Placebo/active

DRUG

Placebo

Placebo/placebo

Trial Locations (2)

20506

Oral Surgery and oral medicine, Malmö University, Malmo

22242

Oral surgery, Universityhospital of Scania, Lund

All Listed Sponsors
collaborator

Skane University Hospital

OTHER

collaborator

University of Copenhagen

OTHER

lead

Malmö University

OTHER